DMRTA2 and embryonal carcinoma: To address the possibility that Dmrta2 affects Pax6 E60 enhancer activity and investigate its mechanism of action, we performed transfection experiments in P19 mouse pluripotent embryonal carcinoma cells that have neurogenic potential (Farah et al., 2000).